27 articles for

April 2010

ORACLE CORP: Nov. 1 Trial Set for Summary Judgment in SAP Suit

The United States District Court for the Northern District of California has scheduled a November 1, 2010 trial date, for SAP AG and Oracle Corp.’s motions for partial summary judgment…

APOLLO GROUP: Nov. 1 Trial Set for Digital-Vending’s Patent Suit

The U.S. District Court for the Eastern District of Texas has set a November 1, 2010 trial date for Digital-Vending Services International Inc.’s patent infringement complaint against Apollo Group, Inc.…

GENERAL MOTORS: Kruse Technology’s Patent Suits Remain Pending

Kruse Technology Partnership’s patent infringement actions against the General Motors Company remain pending. GM is defending itself on several grounds, including non-infringement and invalidity of the patents.

On July 10, 2009,…

ORACLE CORP: Parallel Networks’ Appeal on Patent Suit Pending

Parallel Networks, LLC’s appeal to the summary judgment order in Oracle Corp.’s suit against EpicRealm Licensing, LP on the infringement and validity of U.S. Patent Nos. 5,894,554 and 6,415,335B1, is…

MERCK & CO: December 2010 Trial Set for Patent Suit v. Sandoz

Merck & Co., Inc.’s patent infringement suit against Sandoz Inc. is scheduled to go to trial in December 2010.

In January 2009, the company received notice from Sandoz that it had…

CANON INC: VG Wort Suit Over Printer Copyright Levies Pending

Verwertungsgesellschaft Wort’s suit against Canon Inc. over copyright levies relating to the Company’s single-function printers sold in Germany remains pending.

In Germany, VG Wort, a collecting agency representing certain copyright holders,…

MERCK & CO: Cooperating with FTC Over Ranbaxy Patent Suit Deal

Merck & Co. Inc. is cooperating with the U.S. Federal Trade Commission in responding to a Civil Investigative Demand regarding the settlement of the Ranbaxy patent suit.

The Company and AstraZeneca…

MERCK & CO: Appeals EPO Invalidity Ruling on Alendronate Patent

Merck & Co., Inc. has appealed a decision by the European Patent Office revoking a new patent that covers the once-weekly administration of alendronate remains pending.

In September 2004, the Company…

MERCK & CO: Teva Withdraws Appeal to Ruling on Singulair Patent

Teva Pharmaceuticals Inc. has withdrawn its appeal to a decision upholding the validity of Merck & Co. Inc.’s Singulair patent.

In February 2007, the Company received a notice from Teva Pharmaceuticals,…

MERCK & CO: Trial in Suit v. Ivaz & Dr. Reddy’s Postponed

A trial which had been scheduled for January 2010 with respect to the abbreviated new drug applications filed by IVAX Pharmaceuticals, Inc. and Dr. Reddy’s Laboratories challenging Merck & Co.…

Page 1 of 3123»